UK
***** regulator to
halt approvals for
Indian clinical trials firm
MUMBAI (Reuters) - The UK's healthcare
regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on
clinical trials conducted by India's Quest Life Sciences, due to concerns over the integrity of trial data.
[IMG]http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:F7zBnMyn0Lo[/IMG] [IMG]http://feeds.feedburner.com/~ff/reuters/healthNews?i=**xiQeRaGv4:_**eolycXqo:V_sGLiPBpWU[/IMG]
[IMG]http://feeds.feedburner.com/~r/reuters/healthNews/~4/**xiQeRaGv4[/IMG]